Test parameter | Median value (ranges) | ||
---|---|---|---|
 | Time | ||
Treatment | 24 h | 48 h | 96 h |
Specific stain positivity in ICC (n = 6/each treatment sub-group) | |||
β hCG a | |||
Control | 13.0 (8-18) | 17.5* (11-27) | 23.5(*)(18-32) |
AMA | 11.0 (9-20) | 13.0 (9-22) | 17.0 (11-24) |
hPL a | |||
Control1 | 9.5 (7-12) | 5.5* (9-20) | 21.0(*)(14-30) |
AMA | 8.0 (6-13) | 11.0 (8-18) | 14.5 (10-21) |
Cyto18 neo-epitope a | |||
Control | 2.5 (1-4) | 2.5 (1-5) | 4.5[*](3-8) |
AMA | 3.5 (2-6) | 3.5 (2-7) | 8.5(*)(5-11) |
TUNEL b | |||
Control | 0 (0-3) | 0 (0-2) | 6[*](3-9) |
AMA | 3 (0-5) | 3 (1-7) | 11(*)(6-17) |
Optical densityc in WB analysis (n = 5/each) | |||
β hCG | |||
Control | 20.5 (11-27) | 22.0 (12-28) | 30.5(*)(19-36) |
AMA | 18.0 (9-28) | 21.5 (9-24) | 22.5 (11-27) |
hPL | |||
Control | 9.5 (6-12) | 10.0 (7-18) | 16.5(*) |
AMA | 9.5 (7-13) | 9.5 (6-18) | 11.5 (9-21) |
Cyto18 neo-epitope | |||
Control | 4.0 (2-5) | 4.0 (2-6) | 6.5[*](3-11) |
AMA | 5.5 (2-7) | 5.5 (2-8) | 9.5(*)(5-16) |